The benefits of SUDOSCAN in early diagnosis of diabetic peripheral neuropathy reviewed in The Lancet

Share on facebook
Share on twitter
Share on linkedin
Visuel-spot-News-01-2020

THE BENEFITS OF SUDOSCAN
IN EARLY DIAGNOSIS OF DIABETIC PERIPHERAL NEUROPATHY REVIEWED IN THE LANCET

Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S.
Article title: “Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention”. 
The Lancet Diabetes Endocrinol 2019. Volume 7, Issue 12, p938-948, December 01, 2019.

A recent review has been published in The Lancet Diabetes & Endocrinology, showing the utility
of SUDOSCAN in the early diagnosis of diabetic peripheral neuropathy (DPN).

Early detection of DPN is a key point in the management of diabetic patients; indeed, DPN is a principal cause of diabetic foot ulceration and can lead to foot amputation.

As DPN is a marker of diabetic complications, the authors propose using point-of-care testing to screen for various diabetes complications in a single visit. Large and small fiber assessments (DPN-Check and SUDOSCAN, respectively) can be performed easily to identify neuropathies as shown in the pattern below.

Clinical utility of SUDOSCAN for the diagnosis of diabetic peripheral neuropathy: sensivity 87,5%, specificity 76,2%, intra-observer intraclass correlation coefficient 0,88 and inter-observer intraclass correlation coefficient 0,95

Proposed assessments for a one-stop screening clinic for diabetes complications,
including use of point-of-care devices for DPN
schema-lancet

Adapted from Binns-Hall and colleagues, by permission of the authors. DPN=diabetic peripheral neuropathy. PHQ-9=Patient Health Questionnaire-9. NAFLD=non-alcoholic fatty liver disease. LFTs=liver function tests. ACR=urine albumin-to-creatinine ratio. U&E=urea and electrolytes. eGFR=estimated glomerular filtration rate.

Impeto Medical

Impeto Medical

About SUDOSCAN

SUDOSCAN is a quick and non-invasive test that provides an accurate evaluation of sweat gland function reflecting the status of the autonomic nervous system.

With quantitative and reproducible results, SUDOSCAN allows physicians to detect early and follow-up peripheral neuropathy to monitor disease progression and assess treatment efficacy for better patient management.

SUDOSCAN efficacy has been evaluated in the assessment of small fiber neuropathies in several diseases and compared to reference tests recommended in guidelines.

Recent Posts

Subscribe to receive our scientific news

Name(Required)
Consent(Required)

Website dedicated
to health professionals

I am a health professional

To receive our latest scientific news:

Scroll to Top